Other Infections
AASLD 2017: Women with Fatty Liver Disease at Higher Risk for Heart Disease
- Details
- Category: Steatosis/NAFLD/NASH
- Published on Wednesday, 13 December 2017 00:00
- Written by Liz Highleyman
Women with non-alcoholic fatty liver disease (NAFLD) had a higher risk of cardiovascular events including chest pain and heart failure compared to women without the condition -- and about the same risk as men with NAFLD -- in a study presented at the 2017 AASLD Liver Meeting in October in Washington, DC.
EACS 2017: European AIDS Clinical Society Strengthens HPV Vaccination Advice
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 07 November 2017 00:00
- Written by Keith Alcorn
The European AIDS Clinical Society (EACS) has recommended human papillomavirus (HPV) vaccination for everyone living with HIV aged under 26 and all men who have sex with men up to the age of 40.
HR17: Heroin Combined with Fentanyl Is Driving Overdose Crisis in U.S.
- Details
- Category: Drug Use and Harm Reduction
- Published on Friday, 30 June 2017 00:00
- Written by Liz Highleyman
New sources of heroin and increasing adulteration with fentanyl and other stronger analogs are contributing to a growing epidemic of opioid overdose deaths in several regions of the U.S., researchers reported at the 25th Harm Reduction International Conference last month in Montreal.
California Supervised Injection Bill Stalls, but San Francisco Moves Forward
- Details
- Category: Drug Use and Harm Reduction
- Published on Thursday, 02 November 2017 00:00
- Written by Liz Highleyman
San Francisco would be best served by having several supervised injection sites accompanied by social services for people who use drugs, according to a report from a city task force set up to study the issue.
HR17: People May Use Cannabis and Drug Cocktails as a Form of Harm Reduction
- Details
- Category: Drug Use and Harm Reduction
- Published on Friday, 30 June 2017 00:00
- Written by Liz Highleyman
People who use drugs have come up with innovative strategies that help them reduce harm, including using marijuana to decrease crack use and mixing heroin with methamphetamine to moderate the effects of meth or prolong the duration of heroin, according to presentations at the 25th Harm Reduction International Conference last month in Montreal.
AASLD 2017: Experimental NASH Therapy Improves Liver Fat and Fibrosis
- Details
- Category: Steatosis/NAFLD/NASH
- Published on Wednesday, 01 November 2017 00:00
- Written by Liz Highleyman
GS-0976, an acetyl-CoA carboxylase (ACC) inhibitor being developed by Gilead Sciences, led to significant reductions in liver fat accumulation and fibrosis in people with non-alcoholic steatohepatitis (NASH), according to Phase 2 study results presented at the 2017 AASLD Liver Meeting last week in Washington, DC.
PAS 2017: New Approaches Help Babies with Opioid Withdrawal Syndrome
- Details
- Category: Drug Use and Harm Reduction
- Published on Wednesday, 31 May 2017 00:00
- Written by Liz Highleyman
Letting mothers and babies room together and using methadone or buprenorphine instead of morphine to manage withdrawal symptoms leads to shorter stays and other benefits for newborns with neonatal abstinence syndrome (NAS), according to several presentations at the Pediatric Academic Societies Meeting this month in San Francisco.
Cenicriviroc May Reduce Fibrosis in People with Fatty Liver Disease
- Details
- Category: Steatosis/NAFLD/NASH
- Published on Thursday, 12 October 2017 00:00
- Written by Liz Highleyman
Cenicriviroc, a drug that blocks both CCR5 and CCR2 receptors on immune cells, was associated with a decrease in liver fibrosis in people with non-alcoholic steatosis, a type of fatty liver disease, according to a report in the August 17 online edition of Hepatology.
Coverage of the 2017 Harm Reduction International Conference
- Details
- Category: Drug Use and Harm Reduction
- Published on Wednesday, 31 May 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2017 Harm Reduction International Conference, May 14-17, 2017, in Montreal.
More Articles...
- HR17: Drug Checking Reveals High Levels of Fentanyl Contamination
- HR17: Hydromorphone Works as Well as Heroin-Assisted Drug Addiction Treatment
- HR17: AA Amyloidosis Is an Unrecognized Problem Among People Who Inject Drugs
- PAS 2017: Vaccine Reduces Human Papillomavirus Prevalence Among Young Women
- EASL 2017: Norfloxacin Reduces Risk of Death for People with Decompensated Cirrhosis
Web Design and Development by